2024 |
Q32 Bio Inc.
|
Director |
- |
- |
2024 |
Stoke Therapeutics Inc
|
Interim Executive Chairman of the Board |
- |
- |
2023 |
Stoke Therapeutics Inc
|
Independent Director |
211.8 K |
-6.5 % |
2022 |
Stoke Therapeutics Inc
|
Independent Director |
226.6 K |
-34.6 % |
2022 |
Q32 Bio Inc.
|
Chairman of the Board |
- |
- |
2021 |
Stoke Therapeutics Inc
|
Independent Director |
346.5 K |
-22.0 % |
2021 |
Q32 Bio Inc.
|
Chief Executive Officer and Director |
- |
- |
2020 |
Stoke Therapeutics Inc
|
Independent Director |
444.5 K |
57.1 % |
2020 |
Q32 Bio Inc.
|
President, Chief Executive Officer and Director |
- |
- |
2019 |
Stoke Therapeutics Inc
|
Independent Director |
283.0 K |
226.4 % |
2019 |
Q32 Bio Inc.
|
President, Chief Executive Officer and Director |
- |
- |
2018 |
Stoke Therapeutics Inc
|
Director |
86.7 K |
- |
2018 |
Q32 Bio Inc.
|
President, Chief Executive Officer and Director |
- |
- |
2017 |
Q32 Bio Inc.
|
President, Chief Executive Officer and Director |
- |
- |